When the FGFR4 inhibitor BLU9931 was tested in CRC cells, it was found to significantly inhibit cell proliferation and increase the rate of apoptosis in an inversely proportional manner [7]. The gene discussed is FGFR4; the disease is colorectal carcinoma.